Dr. Andrea Lisotti
University of Bologna, Italy
Email: lisotti.andrea@gmail.com
Qualifications
2010 I Level Master in Science – Clinical
Nutrition and Functional Foods
2008 Italian Medical License
2007 Degree in Medicine – University of Bologna
Publications (Selected)
-
Azzaroli F., Turco L., Lisotti A., Cecinato P.,
Calvanese C., Buonfiglioli F., Cevenini M, Montagnani M, Mazzella G.
Alisporivir for the treatment of chronic HCV. Future virology 2012; 7(1); 9-18.
-
Montagnani M, Giandinoto M, Lisotti A, Galli S,
Azzaroli F, Buonfiglioli F, Turco L, Aldini R, Mazzella G. High Dose Lamivudine
in HBV-Related Cirrhotic Patients with Unsatisfactory Response After Adefovir
Add-On. Dig Dis Sci. 2012 Feb;57(2):561-7.
-
Lisotti A, Azzaroli F, Brillanti S, Mazzella G.
Severe acute autoimmune hepatitis after natalizumab treatment. Dig Liver Dis.
2011 Dec 9. [Epub ahead of print]
-
Azzaroli F, Turco L, Lisotti A, Calvanese C,
Mazzella G. The pharmacological management of intrahepatic cholestasis of
pregnancy. Curr Clin Pharmacol. 2011 Feb;6(1):12-7.
-
Lisotti A., Cornia GL., Morselli-Labate A.M.,
Sartini A., Turco L., Grasso V., Cavina P., Mazzella G., Roda E. Effects
of a fermented milk containingKluyveromyces marxianus B0399 and
Bifidobacterium lactis BB12 in patients with irritable bowel syndrome. Minerva
Gastroenterol Dietol 2011;57(Suppl. 1 al N.2): 1-12.
-
Lisotti A, Roda G, Brillanti S, Roda E.
Reactivation of Crohn's disease after pandemic aH1N1 and seasonal flu
vaccinations. Dig Liver Dis. 2010 Dec;42(12):909-10.
-
Caponi A, Lisotti A, Grenci C, Roda E. Are
therapeutic doses of ursodeoxycholic acid in the cure of primary biliary
cirrhosis inadequate? Some clinical considerations. Minerva Gastroenterol
Dietol. 2008 Dec;54(4):331-4.
-
Lisotti A, Grenci C, Caponi A, Roda E. The
management of NSAIDs therapy: how to minimize upper gastrointestinal tract
damage. Minerva Gastroenterol Dietol. 2008 Dec;54(4):323-9.
-
Lisotti A, Azzaroli F, Buonfiglioli F,
Montagnani M, Alessandrelli F, Mazzella G. Lamivudine treatment for severe
acute HBV hepatitis. Int J Med Sci. 2008;5(6):309-12.
-
Lisotti A, Grenci C, Caponi A, Roda E. Chronic
hepatitis B in 2008. Dig Liv Dis Supplements 2008; suppl 2; 3-6.
-
Azzaroli F., Lisotti A., Calvanese C., Turco L.
and Mazzella G. Chronic NSAIDs therapy and upper gastrointestinal tract:
mechanism of injury, mucosl defense, risk factors for complications development
and clinical management. Book Chapter in “Gastroenterology” ISBN
979-953-307-495-4. Accepted for publication.
-
Grenci C, Lisotti A, Caponi A, Roda E.
Obesity: Risk factor for GI disease? Elisir di salute 2008; 5; 10-13.
-
Grenci C, Lisotti A, Caponi A, Roda E.
Obesity: epidemiology and social impact. The gastroenterologist 2008, 2; 41-3.
-
Grenci C, Lisotti A, Caponi A, Roda E. Le
tante facce della malattia celiaca – un case report. Rivista SIMG 2008 Sep; 4;
59-61.